EPIDIOLEX (cannabidiol) for Seizures Associated with Lennox-Gastaut and Dravet Syndromes


EPIDIOLEX is the first cannabis-based drug to treat both Lennox-Gastaut and Dravet syndromes.

EPIDIOLEX is the first cannabis-based drug to treat both Lennox-Gastaut and Dravet syndromes.



The cannabidiol contained in EPIDIOLEX is effective in reducing the burden of seizures occurring in epilepsy patients.

The cannabidiol contained in EPIDIOLEX is effective in reducing the burden of seizures occurring in epilepsy patients.



Epilepsy patients usually experience electrical disturbances in the brain, which lead to seizures.

Epilepsy patients usually experience electrical disturbances in the brain, which lead to seizures.

<!–
https://www.drugdevelopment-technology.com/projects/epidiolex-cannabidiol-treatment-seizures-associated-lennox-gastaut-syndrome-dravet-syndrome/

by

Leave a Reply